Diagnósticos da América S.A (SA:DASA3) — Market Cap & Net Worth
Market Cap & Net Worth: Diagnósticos da América S.A (DASA3)
Diagnósticos da América S.A (SA:DASA3) has a market capitalization of $828.87 Million (R$4.22 Billion) as of May 4, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #9975 globally and #102 in its home market, demonstrating a 7.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diagnósticos da América S.A's stock price R$3.38 by its total outstanding shares 1249774542 (1.25 Billion). Analyse Diagnósticos da América S.A (DASA3) cash conversion ratio to see how efficiently the company converts income to cash.
Diagnósticos da América S.A Market Cap History: 2015 to 2026
Diagnósticos da América S.A's market capitalization history from 2015 to 2026. Data shows change from $2.32 Billion to $828.87 Million (-8.34% CAGR).
Index Memberships
Diagnósticos da América S.A is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
SAO PAULO SE IGCX INDEX
IGCX
|
$622.91 Billion | 0.13% | #62 of 155 |
Weight: Diagnósticos da América S.A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Diagnósticos da América S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diagnósticos da América S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.03x
Diagnósticos da América S.A's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.32 Billion | $2.79 Billion | $23.81 Million | 0.83x | 97.38x |
| 2016 | $4.07 Billion | $3.04 Billion | $94.74 Million | 1.34x | 42.99x |
| 2017 | $6.35 Billion | $3.40 Billion | $131.44 Million | 1.87x | 48.34x |
| 2018 | $6.30 Billion | $3.93 Billion | $184.38 Million | 1.60x | 34.17x |
| 2019 | $13.88 Billion | $4.36 Billion | $124.78 Million | 3.18x | 111.22x |
| 2020 | $17.43 Billion | $7.04 Billion | -$150.80 Million | 2.48x | N/A |
| 2021 | $8.22 Billion | $10.42 Billion | -$226.57 Million | 0.79x | N/A |
| 2022 | $3.37 Billion | $13.13 Billion | -$386.92 Million | 0.26x | N/A |
| 2023 | $2.36 Billion | $14.25 Billion | -$1.17 Billion | 0.17x | N/A |
| 2024 | $465.93 Million | $15.32 Billion | -$1.20 Billion | 0.03x | N/A |
Competitor Companies of DASA3 by Market Capitalization
Companies near Diagnósticos da América S.A in the global market cap rankings as of May 4, 2026.
Key companies related to Diagnósticos da América S.A by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Diagnósticos da América S.A Historical Marketcap From 2015 to 2026
Between 2015 and today, Diagnósticos da América S.A's market cap moved from $2.32 Billion to $ 828.87 Million, with a yearly change of -8.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$828.87 Million | -25.55% |
| 2025 | R$1.11 Billion | +138.95% |
| 2024 | R$465.93 Million | -80.25% |
| 2023 | R$2.36 Billion | -29.93% |
| 2022 | R$3.37 Billion | -59.02% |
| 2021 | R$8.22 Billion | -52.87% |
| 2020 | R$17.43 Billion | +25.63% |
| 2019 | R$13.88 Billion | +120.26% |
| 2018 | R$6.30 Billion | -0.84% |
| 2017 | R$6.35 Billion | +56.02% |
| 2016 | R$4.07 Billion | +75.63% |
| 2015 | R$2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Diagnósticos da América S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $828.87 Million USD |
| MoneyControl | $828.87 Million USD |
| MarketWatch | $828.87 Million USD |
| marketcap.company | $828.87 Million USD |
| Reuters | $828.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Diagnósticos da América S.A
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and International Diagnostics segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care c… Read more